There is now overwhelming evidence of the efficacy of medicinal cannabis in hundreds of peer reviewed, published scientific papers.
Extraordinary results are being achieved in the treatment of MS, Crohn’s, cancer, Alzheimer’s, epilepsy, spinal injury, pain, PTSD, depression… The list goes on and on. See here for NORML’s “Emerging Clinical Applications For Cannabis & Cannabinoids. A Review of the Recent Scientific Literature, 2000 — 2011″
Cannabis has a transformational effect on some people’s lives, freeing them from pain and suffering without the use of highly toxic pharmaceutical products.
Sativex is a standardised dose cannabis tincture which has been through the MHRA approval process but consequently is sold at a prohibitive, fantastically high price which most British health authorities have rejected.
Bedrocan, the Dutch government’s official grower, produces pharmacologically superior products with a range of cannabinoid contents at much more realistic prices which are exported all over Europe – except for Britain where our government obstinately maintains they “have no medicinal value”.
